Cargando…
Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination
Multiple factors, including vaccine platform and prior vaccinations, influence vaccine responses. We compared antibody responses to CoronaVac (Sinovac) and ChAdOx1-S (AstraZeneca-Oxford) vaccination in 874 healthcare workers in Brazil. As participants were randomised to BCG vaccination or placebo in...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352084/ https://www.ncbi.nlm.nih.gov/pubmed/37465688 http://dx.doi.org/10.3389/fimmu.2023.1172851 |
_version_ | 1785074441976283136 |
---|---|
author | Messina, Nicole L. Sperotto, Mariana G. Puga, Marco A. M. da Silva, Patricia V. de Oliveira, Roberto D. Moore, Cecilia L. Pittet, Laure F. Jamieson, Tenaya Dalcolmo, Margareth dos Santos, Glauce Jardim, Bruno Lacerda, Marcus V. G. Curtis, Nigel Croda, Julio |
author_facet | Messina, Nicole L. Sperotto, Mariana G. Puga, Marco A. M. da Silva, Patricia V. de Oliveira, Roberto D. Moore, Cecilia L. Pittet, Laure F. Jamieson, Tenaya Dalcolmo, Margareth dos Santos, Glauce Jardim, Bruno Lacerda, Marcus V. G. Curtis, Nigel Croda, Julio |
author_sort | Messina, Nicole L. |
collection | PubMed |
description | Multiple factors, including vaccine platform and prior vaccinations, influence vaccine responses. We compared antibody responses to CoronaVac (Sinovac) and ChAdOx1-S (AstraZeneca-Oxford) vaccination in 874 healthcare workers in Brazil. As participants were randomised to BCG vaccination or placebo in the preceding 0-6 months as part of the BCG vaccination to reduce the impact of COVID-19 in healthcare workers (BRACE) trial, we also investigated the influence of recent BCG vaccination on antibody responses to these COVID-19 vaccines. Twenty-eight days after the second dose of each vaccine, ChAdOx1-S induced a stronger anti-spike IgG response than CoronaVac vaccination. Recent BCG vaccination did not impact IgG antibody responses to ChAdOx1-S or CoronaVac. |
format | Online Article Text |
id | pubmed-10352084 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103520842023-07-18 Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination Messina, Nicole L. Sperotto, Mariana G. Puga, Marco A. M. da Silva, Patricia V. de Oliveira, Roberto D. Moore, Cecilia L. Pittet, Laure F. Jamieson, Tenaya Dalcolmo, Margareth dos Santos, Glauce Jardim, Bruno Lacerda, Marcus V. G. Curtis, Nigel Croda, Julio Front Immunol Immunology Multiple factors, including vaccine platform and prior vaccinations, influence vaccine responses. We compared antibody responses to CoronaVac (Sinovac) and ChAdOx1-S (AstraZeneca-Oxford) vaccination in 874 healthcare workers in Brazil. As participants were randomised to BCG vaccination or placebo in the preceding 0-6 months as part of the BCG vaccination to reduce the impact of COVID-19 in healthcare workers (BRACE) trial, we also investigated the influence of recent BCG vaccination on antibody responses to these COVID-19 vaccines. Twenty-eight days after the second dose of each vaccine, ChAdOx1-S induced a stronger anti-spike IgG response than CoronaVac vaccination. Recent BCG vaccination did not impact IgG antibody responses to ChAdOx1-S or CoronaVac. Frontiers Media S.A. 2023-07-03 /pmc/articles/PMC10352084/ /pubmed/37465688 http://dx.doi.org/10.3389/fimmu.2023.1172851 Text en Copyright © 2023 Messina, Sperotto, Puga, da Silva, de Oliveira, Moore, Pittet, Jamieson, Dalcolmo, dos Santos, Jardim, Lacerda, Curtis and Croda https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Messina, Nicole L. Sperotto, Mariana G. Puga, Marco A. M. da Silva, Patricia V. de Oliveira, Roberto D. Moore, Cecilia L. Pittet, Laure F. Jamieson, Tenaya Dalcolmo, Margareth dos Santos, Glauce Jardim, Bruno Lacerda, Marcus V. G. Curtis, Nigel Croda, Julio Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination |
title | Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination |
title_full | Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination |
title_fullStr | Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination |
title_full_unstemmed | Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination |
title_short | Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination |
title_sort | impact of vaccine platform and bcg vaccination on antibody responses to covid-19 vaccination |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352084/ https://www.ncbi.nlm.nih.gov/pubmed/37465688 http://dx.doi.org/10.3389/fimmu.2023.1172851 |
work_keys_str_mv | AT messinanicolel impactofvaccineplatformandbcgvaccinationonantibodyresponsestocovid19vaccination AT sperottomarianag impactofvaccineplatformandbcgvaccinationonantibodyresponsestocovid19vaccination AT pugamarcoam impactofvaccineplatformandbcgvaccinationonantibodyresponsestocovid19vaccination AT dasilvapatriciav impactofvaccineplatformandbcgvaccinationonantibodyresponsestocovid19vaccination AT deoliveirarobertod impactofvaccineplatformandbcgvaccinationonantibodyresponsestocovid19vaccination AT moorececilial impactofvaccineplatformandbcgvaccinationonantibodyresponsestocovid19vaccination AT pittetlauref impactofvaccineplatformandbcgvaccinationonantibodyresponsestocovid19vaccination AT jamiesontenaya impactofvaccineplatformandbcgvaccinationonantibodyresponsestocovid19vaccination AT dalcolmomargareth impactofvaccineplatformandbcgvaccinationonantibodyresponsestocovid19vaccination AT dossantosglauce impactofvaccineplatformandbcgvaccinationonantibodyresponsestocovid19vaccination AT jardimbruno impactofvaccineplatformandbcgvaccinationonantibodyresponsestocovid19vaccination AT lacerdamarcusvg impactofvaccineplatformandbcgvaccinationonantibodyresponsestocovid19vaccination AT curtisnigel impactofvaccineplatformandbcgvaccinationonantibodyresponsestocovid19vaccination AT crodajulio impactofvaccineplatformandbcgvaccinationonantibodyresponsestocovid19vaccination |